After Aphria deal, the new Tilray eyes transformation into a global cannabis brands giant

Company, which will have market value in excess of US$8 billion, is eyeing selling cannabis in everything from drinks to skin creams to snack bars
Finacial Post (Canada)
Monday, May 3, 2021

dollar cannabis2Tilray Inc. shareholders approved the merger with Aphria Inc., creating a cannabis powerhouse that’s both the largest medical marijuana company in Europe and a major player in Canada’s recreational market. The company’s ambitions don’t end there, though. Irwin Simon, the former head of Aphria who is now chairman and chief executive officer of the combined company, has ambitions to transform it from an edgy Canadian marijuana company into a global consumer products giant, potentially selling cannabis in everything from drinks to skin creams to snack bars. The company will have a market value in excess of US$8 billion, making it a giant in the fast-growing cannabis industry.